Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.2 USD | +3.13% | +0.57% | +73.80% |
Jun. 07 | CL King Initiates TransMedics at Buy Rating With $161 Price Target | MT |
Jun. 05 | Transmedics Group Insider Sold Shares Worth $393,986, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on TransMedics Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering TransMedics Group, Inc.
CL King | |
Stephens Inc. | |
Oppenheimer | |
Piper Sandler | |
Morgan Stanley | |
William Blair & Co. | |
Canaccord Genuity | |
Cowen | |
JPMorgan Chase |
EPS Revisions
- Stock Market
- Equities
- TMDX Stock
- Consensus TransMedics Group, Inc.